Another Big Week for RNAi Therapeutics
Insights - Arrowhead Research (ARWR) raised as many questions as it answered this week when the company reported interim results from a mid-stage study of hepatitis B drug … Continue Reading
Read nowSearch Results for tekmira
It Seems the Ebola Trade is Still On After All
Recap - BOOM! Shares of Tekmira Pharmaceuticals (TKMR) climbed from $14 to $20 into Friday’s close after the FDA removed a clinical hold on the company’s Ebola therapeutic, essentially enabling its … Continue Reading
Read nowThis Week’s Small-Cap Healthcare Roundup
Insights - Tekmira Pharmaceuticals (TKMR) was the momentum stock of the week as the spread of Ebola continues in Guinea, Liberia and Sierra Leone, and two infected Americans … Continue Reading
Read nowThe Weekly Biotech Roundup, Here are Our Latest Trades & Insights
Recap - It was a shortened trading week in the U.S. with markets closed the entirety of Friday and half of Thursday, though activity and volatility in the healthcare … Continue Reading
Read now
Regado’s Safety Problem Only Compounds Another Issue: Its Capital Needs
Insights - Shares of Regado Biosciences (RGDO) fell 50% after the company reported an unplanned review of the ongoing REGULATE-PCI phase 3 trial of its novel anti-coagulant, Revolixys (previously … Continue Reading
Read now
Two Technical Setups with Quality Fundamental Backstories
Research - Two technical trade ideas, both names PropThink has followed for some time, with quality, fundamental backstories.
Premium
Ventrus-Assembly Merger Brings Novel HBV Technology Public
Insights - Ventrus and Assembly Pharma plan to merge to develop their novel HBV te.chnology
Read now